PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-20.48%
Negative net income growth while AVGO stands at 200.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.95%
Both reduce yoy D&A, with AVGO at -9.60%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-95.65%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
30.00%
SBC growth while AVGO is negative at -9.26%. John Neff would see competitor possibly controlling share issuance more tightly.
-265.34%
Both reduce yoy usage, with AVGO at -182.35%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-169.06%
AR is negative yoy while AVGO is 135.56%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-81.82%
Negative yoy inventory while AVGO is 650.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-460.00%
Both negative yoy AP, with AVGO at -250.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-400.00%
Both reduce yoy usage, with AVGO at -296.39%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
96.35%
Well above AVGO's 48.39%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-52.12%
Negative yoy CFO while AVGO is 26.25%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
1.60%
Lower CapEx growth vs. AVGO's 14.29%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-100.00%
Negative yoy acquisition while AVGO stands at 305.05%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
64.25%
Purchases growth of 64.25% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
29.47%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
103.45%
We have some outflow growth while AVGO is negative at -94.22%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
132.18%
Lower net investing outflow yoy vs. AVGO's 1568.57%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
100.00%
Debt repayment growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
75.71%
Stock issuance far above AVGO's 34.21%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
4.01%
Buyback growth of 4.01% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.